Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 8,574

Document Document Title
WO/2015/075048A1
The present invention relates to a new process for the preparation of ammeline and/or ammelide from melamine by a solid-to-solid reaction in an aqueous reaction mixture comprising a biocatalyst, wherein the biocatalyst comprises at least...  
WO/2015/071861A3
The current disclosure discloses stereo-selective bioreduction of keto intermediates of various pharmaceutically active compounds to their corresponding hydroxyl compounds by microbes.  
WO/2015/066642A1
Host cells that are engineered to produce benzylisoquinoline alkaloid (BIAs) precursors, such as norcoclaurine (NC) and norlaudanosoline (NL), are provided. The host cells may have one or more engineered modifications selected from: a fe...  
WO/2015/055127A1
The present invention relates to an (R)-praziquantel preparation method, comprising steps of using (R,S)-tetrahydroisoquinoline-1-formate or salts thereof, or 1-(S)-tetrahydroisoquinoline-1-formate or salts thereof as a raw material to p...  
WO/2015/052849A1
The purpose of the present invention is to provide; a phycocyanobilin derivative having an activity of increasing the amount of collagen; and a method for producing the phycocyanobilin derivative. A novel phycocyanobilin derivative havin...  
WO/2015/048452A2
The present disclosure provides for methods of producing hydroxymethylfurfural (HMF) from fructose and other carbohydrates, novel invertase enzymes capable of catalyzing the dehydration of fructose to HMF, and methods of making the novel...  
WO/2015/048452A3
The present disclosure provides for methods of producing hydroxymethylfurfural (HMF) from fructose and other carbohydrates, novel invertase enzymes capable of catalyzing the dehydration of fructose to HMF, and methods of making the novel...  
WO/2015/046848A1
The present invention relates to a method for producing an L-ascorbic acid derivative using a cyclodextrin glucanotransferase mutant enzyme in an enzymatic production method of the ascorbic acid derivative. More specifically, a transgluc...  
WO/2015/035778A1
Disclosed are a method for preparing a benzopyran compound and uses in protecting against pulmonary fibrosis. The structural formula of the benzopyran compound is shown by formula (I), R1 being one selected from hydrogen, C1-C4 alkyl and...  
WO/2015/032911A1
Recombinant microbial cells and methods for producing 5HTP, melatonin and related compounds using such cells are described. More specifically, the recombinant microbial cell may comprise exogenous genes encoding one or more of an L-trypt...  
WO/2015/031441A2
Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical phosphorus or sulfur sources. Fermentation methods using the genetically engineered organisms are also described. Th...  
WO/2015/021561A1
Methods for the manufacture of the therapeutic chemical compound noscapine and noscapine synthesis intermediates comprising contacting a noscapine pathway precursor selected from a first canadine derivative, a first papaveroxine derivati...  
WO/2015/014031A1
The present invention relates to a biological preparation method of (S)-3-(dimethylamino)-1-(thiophene-2-radical)-1-propyl alcohol. According to the method, (S)-3-(dimethylamino)-1-(thiophene-2-radical)-1-acetone or salt thereof is used ...  
WO/2015/004015A1
The present invention relates to the biocatalyzed synthesis of enantiomerically pure (3R) and (3S)-methyl-1,2,3,4-tetrahydroquinoline. Said enantiomerically pure compounds are useful as chiral synthons in organic synthesis and, in partic...  
WO/2015/004455A3
Novel rapamycin analogues and methods for their production with FKBP and/or MIP inhibitory activity with reduced mTOR inhibitory activity with therapeutic potential e.g. as bacterial virulence inhibitors.  
WO/2015/000327A1
A biosynthesis gene cluster of Streptomyces xiamenensis, a purpose, and a bacterial strain are provided. A base sequence of the gene cluster is shown in SEQ ID No.1, and the full base sequence has 5189 bases. Streptomyces xiamenensis CGM...  
WO/2015/001330A1
A process for producing alkyl R-lactate and alkyl S,S-lactyllactate is provided. The process comprises:(a) admixing (i) a first mixture comprising R,R-and S,S-lactide with (ii) a second mixture comprising a C1-C8 alkyl alcohol, the corre...  
WO/2014/209112A1
The invention is directed to a process for the preparation of 2,5- furandicarboxylic acid (FDCA) by fermentation comprising fermenting a suitable starting compound to produce an aqueous solution of a salt of FDCA having a pH of at least ...  
WO/2014/201596A1
Provided is a new Cellulosimicrobium cellulans strain. The microbium cellulans (Cellulosimicrobium cellulans) strain F16 is under strain preservation number CCTCC M 2013201. Also provided is an application of the strain, and the strain i...  
WO/2014/194551A1
Disclosed are a biosynthesis gene cluster of marinacarbolines (MCBs) and a use thereof. The nucleotide sequence of the gene cluster is as shown by positions 1-4222 of SEQ ID NO. 1, and comprises three genes: a gene mcbA responsible for t...  
WO/2014/180085A1
Provided is a biological preparation method for chiral N- protection peridol, in which N-protection piperidone is used as a substrate, and the substrate is subjected to an asymmetric reduction reaction in the presence of a reconstructed ...  
WO/2014/181000A1
The invention provides a process for producing myxopyronin and derivatives of myxopyronin by providing synthetic pathway enzymes in a microorganism or in vitro, e.g. extracellularly. Myxopyronin and derivatives of myxopyronin in the seco...  
WO/2014/177492A1
Process for production of (R)-3-Quinuclidinol by reduction of Quinuclidin-3-one with cofactor and oxidoreductase, characterized in that, the oxidoreductase comprises an amino acid sequence motif MQX1REX2X3WEA, wherein each of X1, X2, X3 ...  
WO/2014/176514A2
The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate, gamma-butyrolactone, 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-CoA and/or putrescine pathway and being capable of producing 4-hydroxy...  
WO/2014/174505A2
The present invention is directed to the preparation of nicotine comprising the enzymatic reduction of 4- (methylamino) -1- (pyridin-3-yl ) butan-1-one.  
WO/2014/172596A3
This disclosure describes biosynthesized compounds including anhydromevalonolactone and β-methyl-δ-valerolactone. This disclosure further describes biosynthetic methods for making these compounds. In some embodiments, the biosynthetic ...  
WO/2014/172596A9
This disclosure describes biosynthesized compounds including anhydromevalonolactone and β-methyl-δ-valerolactone. This disclosure further describes biosynthetic methods for making these compounds. In some embodiments, the biosynthetic ...  
WO/2014/172596A2
This disclosure describes biosynthesized compounds including anhydromevalonolactone and β-methyl-δ-valerolactone. This disclosure further describes biosynthetic methods for making these compounds. In some embodiments, the biosynthetic ...  
WO/2014/165174A2
An isolated fungus having the imperfect stage of Nodulisporium is described. The isolated fungus produces at least one compound selected from the group consisting of 1, 8-cineole, and 1 -methyl- 1,4-cyclohexadiene. A method for producing...  
WO/2014/163301A1
Provided is a method for purifying quinolinic acid, comprising the steps of: preparing a fermentation solution containing at least one of quinolinic acid and a salt thereof; removing microbial cells from the fermentation solution; prepar...  
WO/2014/155214A1
The invention pertains to processes to produce dry biomass of pyripyropene producer organisms, processes to obtain pyripyropenes from such dry biomass, as well as to processes to produce compounds of Formula (III) and/or Formula (IV) and...  
WO/2014/154785A1
The invention relates to a method for stabilising a biomass of microalgae containing oxidation-sensitive metabolites selected from the group consisting of carotenoids (lutein, etc.), monounsaturated and polyunsaturated fatty acids (palmi...  
WO/2014/147578A4
The invention relates to the production of rifamycin analogs against drug resistant bacteria. The invention also relates to antibacterial compounds against drug resistant mycobacteria. The invention also provides for pharmaceutical compo...  
WO/2014/147578A3
The invention relates to the production of rifamycin analogs against drug resistant bacteria. The invention also relates to antibacterial compounds against drug resistant mycobacteria. The invention also provides for pharmaceutical compo...  
WO/2014/140786A1
A fed-batch fermentation method for production of bacteriochlorophyll a (Bchla) from Rhodovulum sulfidophilum, is provided wherein the growth medium contains an inorganic nitrogen compound as the nitrogen source and during fermentation t...  
WO/2014/144135A3
Provided herein are compositions and methods for improved production of acetyl-CoA and acetyl-CoA derived compounds in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence...  
WO/2014/145550A2
A corner bead for wallboard applications comprising a polymeric core having a bonding surface for bonding to wallboard wherein the bonding surface has applied thereto a water activated adhesive which is bonded to the polymeric core by a ...  
WO/2014/131995A1
A method for the enzymatic synthesis of diosmetin derivatives of formula (III):  
WO/2014/132902A1
Provided are: a compound represented by structural formula (1); a production method therefor; a microorganism capable of producing said compound; and a compound-containing composition, an anticancer agent, and an anti-Helicobacter pylori...  
WO/2014/131247A1
Provided is a method for synthesizing levo-praziquantel, comprising subjecting a chemically synthesized raceme or a certain enantiomer to a dynamic kinetic resolution catalyzed with a nitrile hydratase to produce an optically pure chiral...  
WO/2014/130613A3
Compounds of Formula (I) are useful as modulators of glycosylation. Compounds of Formula (I) have the following structure: (I) and the definitions of the other variables are provided herein.  
WO/2014/122109A1
The invention relates to enzymatic methods for preparing indigo and derivatives thereof, using peroxygenase and hydrogen peroxide.  
WO/2014/112387A1
The purpose of the invention is to provide a novel antitrypanosomal drug. The invention pertains to actinoallolides (A, B, C, D, and/or E), which are novel compounds produced by the actinomycete MK 10-036; to a method for producing said ...  
WO/2014/094462A1
The present invention provides a biological preparation method of (S)-3-methylamino-1-(2-thienyl)-1-propyl alcohol, wherein 3-methylamino-1-(2-thienyl)-1-acetone is used as a substrate; under a condition that a biocatalyst ketoreductase,...  
WO/2014/086702A3
The present invention relates to a biocatalytic process for preparing furandimethanols from hydroxymethylfurfurals, catalysed by suitable alcohol dehydrogenase enzymes, and to the use of the dimethanols thus prepared for preparation of o...  
WO/2014/080666A1
A diterpene compound represented by formula (VII) is a novel diterpene compound having an excellent skin-whitening effect. The present invention provides: a skin-whitening agent comprising a novel diterpene compound; and a method for pro...  
WO/2014/056006A1
The invention relates to enzymes for transforming ergopeptines, in particular by means of hydrolytic cleavage. Said enzymes are α/ β hydrolases which are hydrolytically cleaved in the cyclol ring of the ergopeptines for the transformat...  
WO/2014/056007A3
The invention relates to an enzyme preparation for transforming ergopeptines, containing at least one α/ß hydrolase which is hydrolytically cleaved in the cyclol ring of the ergopeptines and at least one amidase transforming the degrad...  
WO/2014/056007A2
The invention relates to an enzyme preparation for transforming ergopeptines, containing at least one α/ß hydrolase which is hydrolytically cleaved in the cyclol ring of the ergopeptines and at least one amidase transforming the degrad...  
WO/2014/036395A1
The invention provides a series of bioactive small molecules that target expanded r(CGG) repeats, termed r(CGG)exp, that causes Fragile X-associated Tremor Ataxia Syndrome (FXTAS). The compound was identified by using information on the ...  

Matches 151 - 200 out of 8,574